Roelens M, de Masson A, Andrillon A, Ram-Wolff C, et al. Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sezary syndrome. Br J Dermatol 2022;186:1010-1025.
PMID: 35041763